An observational study suggests that administration of phosphorus binders dramatically improves survival rates in patients on incident hemodialysis—even in those without hyperphosphatemia. Randomized clinical trials should drive changes in the relevant clinical practice.
- Joachim H. Ix
- Glenn M. Chertow
